Skip to main content

After placing an order, please send a copy of your ID along with

your order number to fitfamcbd@gmail.com

All sales are final

THC Inhaler - Natural Terp - 150 Puff Capacity

$40.00
Write a Review

Important Notice: The FitFam THC Inhaler is not a medical device and is not marketed, labeled, or sold for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. It is a consumable hemp product sold over the counter to adults 21 years of age or older with valid government-issued identification, in full compliance with Texas Health and Safety Code Chapter 443.

 

FITFAM THC INHALER

150 Metered Actuations | Mechanical Pressurized Delivery

The FitFam THC Inhaler is a mechanically actuated, pressurized metered-dose hemp inhalation product designed to deliver a consistent quantity of hemp-derived Delta-9 THC with each actuation.

It contains:

  • No battery
  • No heating element
  • No electronic circuitry
  • No coil
  • No combustion

The product uses a pressurized HFA-134a propellant system to deliver the formulation mechanically through a metering valve.

PRODUCT DETAILS

Capacity: Approximately 150 metered actuations

Available varieties:

  • Natural Terp
  • Cool Mint

Delivery system: Mechanical pressurized metered-dose aerosol

Propellant: HFA-134a

Cannabinoid source: Hemp-derived Delta-9 THC

Age restriction: For adults 21 years of age or older only


CURRENT LABORATORY TESTING

Independent cannabinoid testing was performed by SC Labs using HPLC-DAD methodology.

Natural Terp

SC Labs Sample: 260814Q003

Delta-9 THC in analytical sample:

7.549 mg/g

0.7549%

THCA: Not Detected

Delta-8 THC: Not Detected

Cool Mint

SC Labs Sample: 260814Q004

Delta-9 THC in analytical sample:

7.639 mg/g

0.7639%

THCA: Not Detected

Delta-8 THC: Not Detected

These laboratory percentages represent the cannabinoid concentration of the non-propellant formulation submitted for analytical testing.

The SC Labs COAs identify a 1.0-gram analytical sample and do not include HFA-134a propellant as part of the reported analytical sample mass.


FINISHED PRODUCT FORMULATION

The finished FitFam THC Inhaler is a pressurized formulation consisting of both the cannabinoid-containing liquid formulation and HFA-134a propellant.

Manufacturer formulation records document approximately:

6.50 grams HFA-134a propellant

plus approximately:

3.64 to 3.66 grams non-propellant formulation

for a total finished formulation of approximately:

10.14 to 10.16 grams per canister

HFA-134a therefore represents approximately 64% of the total finished formulation by mass.


FINISHED-FORMULATION THC CALCULATION

Because SC Labs measures the non-propellant analytical formulation, the laboratory percentage should not be confused with the concentration of the complete finished pressurized formulation.

Using the actual SC Labs assay results together with the manufacturer-documented formulation masses:

Natural Terp

7.549 mg/g × approximately 3.66 g non-propellant formulation

= approximately 27.63 mg Delta-9 THC

27.63 mg ÷ approximately 10.16 g total finished formulation

= approximately 0.272% Delta-9 THC

Cool Mint

7.639 mg/g × approximately 3.64 g non-propellant formulation

= approximately 27.81 mg Delta-9 THC

27.81 mg ÷ approximately 10.14 g total finished formulation

= approximately 0.274% Delta-9 THC

Both calculated finished-formulation concentrations are below 0.300% Delta-9 THC when the complete pressurized formulation, including HFA-134a, is used as the product-level denominator.

Manufacturer formulation records independently indicate a nominal finished-product concentration of approximately 0.287% Delta-9 THC, based on the documented amount and potency of the hemp-derived Delta-9 ingredient.


IMPORTANT TECHNICAL NOTE

Texas law establishes a maximum Delta-9 THC concentration of 0.3% on a dry-weight basis for consumable hemp products.

Current Texas hemp rules do not appear to provide a specific analytical methodology for determining THC concentration in a pressurized metered-dose hemp product containing a volatile HFA propellant.

For this reason, established pressurized metered-dose inhaler principles are referenced as relevant technical guidance for understanding formulation composition, metered delivery, and per-actuation performance.

These references are made solely because pMDI technology provides the closest established technical framework for analyzing this type of pressurized delivery system.

They are not intended to represent or imply that the FitFam THC Inhaler is a pharmaceutical drug or medical device.

The FitFam THC Inhaler is marketed and sold as a consumable hemp product for adult use.


HOW THE DELIVERY SYSTEM WORKS

The finished canister contains both the hemp-derived formulation and HFA-134a propellant under pressure.

When the inhaler is actuated:

  1. A mechanical metering valve releases a predetermined amount of the pressurized formulation.
  2. The HFA-134a propellant rapidly expands and volatilizes after leaving the actuator.
  3. The remaining formulation is dispersed as a fine aerosol.

No battery, heating coil, combustion process, or electronic vaporization system is used.


CERTIFICATES OF ANALYSIS

Batch-specific Certificates of Analysis are available for review.

Natural Terp

SC Labs Sample 260814Q003

Batch R2FFC08122026NT01CO

Cool Mint

SC Labs Sample 260814Q004

Batch R2FFC08122026CM02CO


REQUIRED CONSUMER WARNINGS

Keep out of reach of children.

Product may contain tetrahydrocannabinol (THC) and can cause a user to fail a drug test.

All THCs have psychoactive properties.

Pregnant or nursing women should consult a healthcare provider before use.

This product has not been evaluated by the FDA.

For adults 21 years of age or older only.

Do not drive or operate machinery after consuming THC.


FDA AND MEDICAL DISCLAIMER

This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

Nothing on this page should be interpreted as medical advice.

References to pressurized metered-dose inhaler technology, HFA-134a, laboratory methods, or pharmaceutical technical standards are provided solely to describe the engineering and analytical characteristics of the product and do not constitute a medical claim.